Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Pioglitazone 15 mg [actos]'s trials
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
Pioglitazone 15 MG [Actos]
Ongoing
Recruiting
Phase 4
Open NCT06989723 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
